References
Ziegler S, Alt E, Brunner M, Speiser W, Minar E (2004) Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients. Ann Hematol 83:92–94
Ziegler S, Maca T, Alt E, Speiser W, Schneider B, Minar E (2002) Monitoring of antiplatelet therapy with the PFA-100® in peripheral angioplasty patients. Platelets 13:493–497
Patrono C (2003) Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 1:1710–1713
Roller RE, Dorr A, Ulrich S, Pilger E (2002) Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyser PFA-100. Blood Coagul Fibrinolysis 13:277–281
Mueller T, Haltmayer M, Poelz W, Haidinger D (2003) Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease. Vasc Endovasc Surg 37:117–123
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poulsen, T.S., Mickley, H. Is the antiplatelet effect of aspirin affected by systemic inflammation?. Ann Hematol 83, 728 (2004). https://doi.org/10.1007/s00277-004-0940-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0940-1